ATLASEmergent BioSolutions (EBS) earnings date: Nov 2, 2026
Emergent BioSolutions (EBS) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 2, 2026, after the close. Analysts expect EPS of -$0.45.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on EBS
| Last price | $6.67 (-2.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.3% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Emergent BioSolutions stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Emergent BioSolutions reports on Nov 2, 2026. One email the day before, with ATLAS’s read on Emergent BioSolutions. You can switch it off at any time.
Alert me before EBS reportsFree to start. Creating an account takes under a minute.
Notify me when Emergent BioSolutions reports
Track EBS free Add Emergent BioSolutions to a free ATLAS watchlist and see its next report date in one place.
EBS earnings at a glance
| Next report (confirmed) | Mon, Nov 2, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.45 |
| Last report | Aug 5, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +2.6% |
| Average move around a report | ±14.3% (last 5) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
Emergent BioSolutions earnings history: last 5 reports
Emergent BioSolutions last reported on Aug 5, 2026: EPS of $0.60 against an estimate of $0.11 (+445.5% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 5, 2026 | $0.11 | $0.60 | +445.5% | Beat | -29.9% |
| May 29, 2026 | $0.74 | $0.92 | +24.3% | Beat | -7.5% |
| Apr 30, 2026 | -$0.25 | $0.21 | +184.0% | Beat | +6.0% |
| Mar 24, 2026 | -$0.40 | -$1.00 | -150.0% | Miss | +2.0% |
| Feb 26, 2026 | $0.11 | -$0.43 | -490.9% | Miss | -26.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for EBS
See the fair value, the probability range and the earnings history of Emergent BioSolutions on its ATLAS page.
Emergent BioSolutions (EBS) stock analysisPlans from €3.99 a month.
Emergent BioSolutions earnings: frequently asked questions
When does Emergent BioSolutions (EBS) report earnings?
Emergent BioSolutions is scheduled to report on Monday, November 2, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for EBS?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.45 per share (USD). Estimates can change before the report.
How often does EBS beat earnings estimates?
Of its last 5 reports with a recorded result, Emergent BioSolutions beat the EPS estimate 3 times; the average surprise was +2.6%. Past results do not predict the next one.
How much does EBS move around earnings?
Over its last 5 reports the stock moved an average of 14.3% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Emergent BioSolutions beat earnings estimates last quarter?
Emergent BioSolutions last reported on Aug 5, 2026: EPS of $0.60 against an estimate of $0.11 (+445.5% surprise), a beat.
How much does EBS usually move in a day?
On a normal trading day the ATLAS model puts EBS’s one-day range at about ±4.3%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 2, 2026
Educational information, not investment advice. Disclaimer